JANELL LOWE: Open Payments
NPI 1710236039 · CHATTANOOGA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,935 in 62 payments from 36 companies in 2025. Trend: 2023 $880 · 2024 $455 · 2025 $1,935
Food & beverage: $1,762Education: $174
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 5 | $203 |
| AstraZeneca Pharmaceuticals LP | 6 | $155 |
| Galvanize Therapeutics, Inc | 1 | $151 |
| JAZZ PHARMACEUTICALS INC. | 1 | $133 |
| Incyte Corporation | 2 | $99 |
| SANOFI-AVENTIS U.S. LLC | 1 | $96 |
| Janssen Biotech, Inc. | 3 | $74 |
| Novartis Pharmaceuticals Corporation | 3 | $69 |
| E.R. Squibb & Sons, L.L.C. | 3 | $67 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $66 |
Products named: Vyloy, ALIYA SYSTEM, ZIIHERA, SARCLISA, OPDUALAG, CALQUENCE, TECVAYLI, Trodelvy.
Industry payments across TN — which companies pay providers there.
